Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

NCT00244803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2016-08-31

No results posted yet for this study

Summary

The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.

Conditions

  • Human Immunodeficiency Virus

Sponsors & Collaborators

Principal Investigators

  • Joseph Cofrancesco Jr., M.D. · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00244803 on ClinicalTrials.gov